Cronos Group Inc. (TSE:CRON - Get Free Report) was down 0.4% during trading on Thursday . The company traded as low as C$2.80 and last traded at C$2.82. Approximately 35,393 shares traded hands during trading, a decline of 81% from the average daily volume of 184,336 shares. The stock had previously closed at C$2.83.
Cronos Group Price Performance
The firm has a 50-day simple moving average of C$2.73 and a 200-day simple moving average of C$2.70. The firm has a market cap of C$739.38 million, a P/E ratio of -15.58, a PEG ratio of 0.12 and a beta of 1.02. The company has a current ratio of 24.24, a quick ratio of 24.01 and a debt-to-equity ratio of 0.17.
Cronos Group Company Profile
(
Get Free Report)
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth.
Featured Articles
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
